Ad5.F35-hGCC-PADRE

· Thomas Jefferson University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ad5.F35-hGCC-PADRE, covering 2025-08-22 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma [Phase 2]